The effects of plant stanol esters on intestinal mucosal gene expression profiles and microbiota composition in healthy human subjects. - Plant stanols and gene expression profile

niversiteit Maastricht0 个研究点目标入组 20 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•unstable body weight (weight gain or loss > 3 kg in the past two months) - active cardiovascular diseases like congestive heart failure or recent (<6 months) event (acute myocardial infarction, cerebral vascular incident) - severe medical conditions that might interfere with the study such as epilepsy, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease and rheumatoid arthritis) - indication for treatment with cholesterol-lowering drugs according to the Dutch Cholesterol Consensus - use of medication such as corticosteroids, diuretics or lipid lowering therapy - abuse of drug or alcohol (>21 units per week) - not willing to stop the consumption of vitamin supplements, fish oil capsules or products rich in sterol or stanol esters - use of an investigational product within another biomedical study within the previous month - pregnant or breast-feeding women - not willing to give up being a blood donor (or having donated blood) from 8 weeks before the start of the study and during the study - current smoker - anemia. with a Hb-level below 7.5 mmol/L for men and below 7.0 mmol/L for women, as indicated by the blood bank of Maastricht - gastrointestinal diseases - not willing to stop the consumption of probiotica and antibiotica during the study

发起方